Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Short-term Investments (2017 - 2025)

Entera Bio has reported Short-term Investments over the past 4 years, most recently at $7.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments changed N/A year-over-year to $7.8 million, compared with a TTM value of $7.8 million through Dec 2025, changed N/A, and an annual FY2025 reading of $7.8 million, changed N/A over the prior year.
  • Short-term Investments came in at $7.8 million for Q4 2025, up from $173000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $7.8 million in Q4 2025 to a low of $7.8 million in Q4 2025.